PRJNA729188
To explore Shenling Baizhu powder for improving chronic inflammation and preventing type 2 diabetes in ZDF rats based on intestinal flora+gut metagenome
Fifty rats were randomly divided into normal control group (L), model control group (Z), SLBZP low-dose group (LS), SLBZP medium-dose group (MS), and SLBZP high-dose group (HS). Starting from 5 weeks of age, gavage ultrapure water and different doses of SLBZP decoction, monitor basic indicators such as body weight and blood glucose every week, and collect stool and intestinal contents for 16S rRNA sequencing and metabolomics at 9 weeks of age.